Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The impact of image acquisition time on registration, delineation and image quality for magnetic resonance guided radiotherapy of prostate cancer patients.
Nowee ME, van Pelt VWJ, Walraven I, Simões R, Liskamp CP, Lambregts DMJ, Heijmink S, Schaake E, van der Heide UA, Janssen TM. Nowee ME, et al. Among authors: heijmink s. Phys Imaging Radiat Oncol. 2021 Jul 24;19:85-89. doi: 10.1016/j.phro.2021.07.002. eCollection 2021 Jul. Phys Imaging Radiat Oncol. 2021. PMID: 34355071 Free PMC article.
Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation.
Steenbergen P, Haustermans K, Lerut E, Oyen R, De Wever L, Van den Bergh L, Kerkmeijer LG, Pameijer FA, Veldhuis WB, van der Voort van Zyp JR, Pos FJ, Heijmink SW, Kalisvaart R, Teertstra HJ, Dinh CV, Ghobadi G, van der Heide UA. Steenbergen P, et al. Radiother Oncol. 2015 May;115(2):186-90. doi: 10.1016/j.radonc.2015.04.012. Epub 2015 Apr 29. Radiother Oncol. 2015. PMID: 25935742 Free article.
Magnetic resonance imaging for prostate cancer radiotherapy.
Dinh CV, Steenbergen P, Ghobadi G, Heijmink SW, Pos FJ, Haustermans K, van der Heide UA. Dinh CV, et al. Phys Med. 2016 Mar;32(3):446-51. doi: 10.1016/j.ejmp.2016.01.484. Epub 2016 Feb 5. Phys Med. 2016. PMID: 26858164 Free article. Review.
Gross tumour delineation on computed tomography and positron emission tomography-computed tomography in oesophageal cancer: A nationwide study.
Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, van Lier ALHMW, Heijmink SW, Aleman BMP, Nijkamp J, Meijer GJ, Lips IM; Dutch National Platform for Radiotherapy of Gastrointestinal Tumours (LPRGE) group. Nowee ME, et al. Among authors: heijmink sw. Clin Transl Radiat Oncol. 2018 Oct 26;14:33-39. doi: 10.1016/j.ctro.2018.10.003. eCollection 2019 Jan. Clin Transl Radiat Oncol. 2018. PMID: 30519647 Free PMC article.
Gross Tumor Delineation in Esophageal Cancer on MRI Compared With 18F-FDG-PET/CT.
Vollenbrock SE, Nowee ME, Voncken FEM, Kotte ANTJ, Goense L, van Rossum PSN, van Lier ALHMW, Heijmink SW, Bartels-Rutten A, Wessels FJ, Aleman BMP, Dewit L, Kerkmeijer LGW, Jansen EPM, Intven M, Lips IM, Meijer GJ, Nijkamp J. Vollenbrock SE, et al. Among authors: heijmink sw. Adv Radiat Oncol. 2019 Apr 24;4(4):596-604. doi: 10.1016/j.adro.2019.04.004. eCollection 2019 Oct-Dec. Adv Radiat Oncol. 2019. PMID: 31673653 Free PMC article.
Biochemical recurrence prediction after radiotherapy for prostate cancer with T2w magnetic resonance imaging radiomic features.
Dinis Fernandes C, Dinh CV, Walraven I, Heijmink SW, Smolic M, van Griethuysen JJM, Simões R, Losnegård A, van der Poel HG, Pos FJ, van der Heide UA. Dinis Fernandes C, et al. Phys Imaging Radiat Oncol. 2018 Aug 6;7:9-15. doi: 10.1016/j.phro.2018.06.005. eCollection 2018 Jul. Phys Imaging Radiat Oncol. 2018. PMID: 33458399 Free PMC article.
Identification of the optimal combination dosing schedule of neoadjuvant ipilimumab plus nivolumab in macroscopic stage III melanoma (OpACIN-neo): a multicentre, phase 2, randomised, controlled trial.
Rozeman EA, Menzies AM, van Akkooi ACJ, Adhikari C, Bierman C, van de Wiel BA, Scolyer RA, Krijgsman O, Sikorska K, Eriksson H, Broeks A, van Thienen JV, Guminski AD, Acosta AT, Ter Meulen S, Koenen AM, Bosch LJW, Shannon K, Pronk LM, Gonzalez M, Ch'ng S, Grijpink-Ongering LG, Stretch J, Heijmink S, van Tinteren H, Haanen JBAG, Nieweg OE, Klop WMC, Zuur CL, Saw RPM, van Houdt WJ, Peeper DS, Spillane AJ, Hansson J, Schumacher TN, Long GV, Blank CU. Rozeman EA, et al. Among authors: heijmink s. Lancet Oncol. 2019 Jul;20(7):948-960. doi: 10.1016/S1470-2045(19)30151-2. Epub 2019 May 31. Lancet Oncol. 2019. PMID: 31160251 Clinical Trial.
59 results